All News

During oral arguments, the justices asked skeptical questions regarding Republican state efforts to get the Affordable Care Act (ACA) overturned.

FDA approves a coronavirus disease 2019 (COVID-19) antibody treatment; North Dakota braces hospitals for surging cases; fruit consumption among children is low.

What is feasible for one person may be unaffordable for another, said Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor, Midwestern University Chicago College of Pharmacy, who practices at the Northwestern Medicine Infectious Disease Center.

David Weisenfeld, JD, legal editor at XpertHR, previews how employment law rulings may be affected by the Senate's recent confirmation of Justice Amy Coney Barrett to the Supreme Court.

New data to be presented at the American Academy of Ophthalmology’s Annual Meeting highlight the efficacy of Tepezza (teprotumumab), the first and only FDA approved medicine for thyroid eye disease.

Pfizer said interim data on its coronavirus disease 2019 (COVID-19) vaccine show 90% efficacy; meanwhile, President-elect Joe Biden released the names of his coronavirus advisory board.

Medicare Part B outpatient premiums will increase in 2021; nursing homes report rises in coronavirus disease 2019 (COVID-19) cases; advisory panel votes down Biogen's Alzheimer disease drug.

In contrast with previous research, a new study suggests that women with interstitial lung disease (ILD) may not need to avoid or terminate pregnancy.

The study also found that Black patients with rheumatoid arthritis (RA) are more likely to be prescribed glucocorticoids, which come with a risk of serious long-term adverse effects.

Overuse of reliever inhalers among adult patients with asthma is prevalent, but does not necessarily translate into higher all-cause health care utilization (HCU), according to a study published in Scientific Reports.

Patients with chronic migraine who received a combination therapy of erenumab and onabotulinumtoxinA exhibited significant reductions in monthly headache days and monthly migraine days.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Although the fate of the Senate remains undecided, President-elect Joe Biden’s Democratic win spells major changes for both the handling of the coronavirus disease 2019 pandemic and health care in the United States.

Categorizing by eosinophilic/noneosinophilic subtype enables better targeted treatment, noted Anne Reihman, MD, third-year pulmonary and critical care fellow, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.

Having node-positive, estrogen receptor–positive breast cancer indicated a greater likelihood of overall survival following chemotherapy, despite having several comorbidities, after adjustment for confounders.

Combination bronchodilators are available and have been shown to improve both symptoms and lung function, explained Nicola Hanania, MD, MS, of Baylor College of Medicine.

The study emphasizes the importance of school support and other psychosocial interventions considering specific deficits across adaptive skills in patients with neuromuscular diseases (NMDs).

A vegan diet is one that physicians may want to consider for their patients with painful diabetic neuropathy, according to a recent review.

A group of patient advocacy organizations released their 100-day agenda for the next president.

Individual-level low socioeconomic status (SES) was found to be significantly associated with increased mortality in Korean patients with Parkinson disease, whereas regional-level SES was not.

Serum fatty acid–binding protein 4 levels were increased in patients with heart failure with preserved ejection fraction (HFpEF), associated with cardiac remodeling and dysfunction, and linked to poor outcomes.

This week, the top news in managed care included top health care takeaways from the 2020 general election; a Q&A with Dr William Shrank on connecting Medicare Advantage providers and patients; Managed Care Cast discusses balancing evidence with action amid the COVID-19 pandemic.

A new study suggests a potential new marker that could be used to track response to therapy and disease progression in patients with multiple myeloma.

The researchers of the review discuss the reported impact of novel therapies for spinal muscular atrophy (SMA) and highlight the need for long-term data and monitoring of respiratory outcomes.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

AstraZeneca will begin clinical trials of its coronavirus disease 2019 (COVID-19) vaccine in China; 2 states impose stricter mask mandates; President Donald Trump wins counties with highest infection rates.

Vitamin D used as an adjuvant therapy in children with severe atopic dermatitis may improve clinical outcomes, according to a recent study.

New data show combining glucagon-like peptide-1 receptor agonist (GLP-1 RA) exenatide plus sodium–glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin remains effective after 2 years for type 2 diabetes (T2D) uncontrolled with metformin.

New results from the phase 3 ULTIMATE trial show Novartis’ Cosentyx (secukinumab) demonstrated significant treatment response on synovitis in patients with active psoriatic arthritis (PsA) compared with placebo.

Many patients with acute lymphoblastic leukemia (ALL) who undergo chemotherapy end up back in the hospital within 30 days. A new study points out the reasons and opportunities for prevention.